Lenacapavir with Fostemsavir in a Multidrug-Resistant HIV-Infected Hemodialysis Patient

We report a hemodialysis MDR HIV-infected patient switched to fostemsavir with lenacapavir plus lamivudine for more than a year. She maintained a suppressed viral replication and did not present any clinical or biological drug-related side effects. The combination of lenacapavir plus fostemsavir loo...

Full description

Saved in:
Bibliographic Details
Main Authors: Ferdinand Bigirimana, Sigi Van den Wijngaert, Christelle Fosso, Karolien Stoffels, Charlotte Martin, Evelyne Maillart, Philippe Clevenbergh
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Case Reports in Infectious Diseases
Online Access:http://dx.doi.org/10.1155/2023/8865265
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850212472860966912
author Ferdinand Bigirimana
Sigi Van den Wijngaert
Christelle Fosso
Karolien Stoffels
Charlotte Martin
Evelyne Maillart
Philippe Clevenbergh
author_facet Ferdinand Bigirimana
Sigi Van den Wijngaert
Christelle Fosso
Karolien Stoffels
Charlotte Martin
Evelyne Maillart
Philippe Clevenbergh
author_sort Ferdinand Bigirimana
collection DOAJ
description We report a hemodialysis MDR HIV-infected patient switched to fostemsavir with lenacapavir plus lamivudine for more than a year. She maintained a suppressed viral replication and did not present any clinical or biological drug-related side effects. The combination of lenacapavir plus fostemsavir looks promising in terms of safety and efficacy even in patients with end-stage renal disease awaiting renal transplant. Both drugs are first in class ARVs so that there is no cross resistance with previous drugs, maintaining their efficacy against MDR HIV.
format Article
id doaj-art-89ee7c1e1ef148b2be34e82cb89c0539
institution OA Journals
issn 2090-6633
language English
publishDate 2023-01-01
publisher Wiley
record_format Article
series Case Reports in Infectious Diseases
spelling doaj-art-89ee7c1e1ef148b2be34e82cb89c05392025-08-20T02:09:19ZengWileyCase Reports in Infectious Diseases2090-66332023-01-01202310.1155/2023/8865265Lenacapavir with Fostemsavir in a Multidrug-Resistant HIV-Infected Hemodialysis PatientFerdinand Bigirimana0Sigi Van den Wijngaert1Christelle Fosso2Karolien Stoffels3Charlotte Martin4Evelyne Maillart5Philippe Clevenbergh6Infectious Diseases DepartmentAids Reference LaboratoryNephrology and Dialysis DepartmentAids Reference LaboratoryInfectious Diseases DepartmentInfectious Diseases DepartmentInfectious Diseases DepartmentWe report a hemodialysis MDR HIV-infected patient switched to fostemsavir with lenacapavir plus lamivudine for more than a year. She maintained a suppressed viral replication and did not present any clinical or biological drug-related side effects. The combination of lenacapavir plus fostemsavir looks promising in terms of safety and efficacy even in patients with end-stage renal disease awaiting renal transplant. Both drugs are first in class ARVs so that there is no cross resistance with previous drugs, maintaining their efficacy against MDR HIV.http://dx.doi.org/10.1155/2023/8865265
spellingShingle Ferdinand Bigirimana
Sigi Van den Wijngaert
Christelle Fosso
Karolien Stoffels
Charlotte Martin
Evelyne Maillart
Philippe Clevenbergh
Lenacapavir with Fostemsavir in a Multidrug-Resistant HIV-Infected Hemodialysis Patient
Case Reports in Infectious Diseases
title Lenacapavir with Fostemsavir in a Multidrug-Resistant HIV-Infected Hemodialysis Patient
title_full Lenacapavir with Fostemsavir in a Multidrug-Resistant HIV-Infected Hemodialysis Patient
title_fullStr Lenacapavir with Fostemsavir in a Multidrug-Resistant HIV-Infected Hemodialysis Patient
title_full_unstemmed Lenacapavir with Fostemsavir in a Multidrug-Resistant HIV-Infected Hemodialysis Patient
title_short Lenacapavir with Fostemsavir in a Multidrug-Resistant HIV-Infected Hemodialysis Patient
title_sort lenacapavir with fostemsavir in a multidrug resistant hiv infected hemodialysis patient
url http://dx.doi.org/10.1155/2023/8865265
work_keys_str_mv AT ferdinandbigirimana lenacapavirwithfostemsavirinamultidrugresistanthivinfectedhemodialysispatient
AT sigivandenwijngaert lenacapavirwithfostemsavirinamultidrugresistanthivinfectedhemodialysispatient
AT christellefosso lenacapavirwithfostemsavirinamultidrugresistanthivinfectedhemodialysispatient
AT karolienstoffels lenacapavirwithfostemsavirinamultidrugresistanthivinfectedhemodialysispatient
AT charlottemartin lenacapavirwithfostemsavirinamultidrugresistanthivinfectedhemodialysispatient
AT evelynemaillart lenacapavirwithfostemsavirinamultidrugresistanthivinfectedhemodialysispatient
AT philippeclevenbergh lenacapavirwithfostemsavirinamultidrugresistanthivinfectedhemodialysispatient